CardioDx Inc - Strategic SWOT Analysis Review

CardioDx Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

CardioDx Inc (CardioDx) is a molecular diagnostics company, which specializes in cardiovascular genomics. It develops clinically validated tests to help clinicians personalize care for patients with cardiovascular diseases such as coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD test, is used for assessing if the patients suffering with chest pain or other symptoms are having obstructive CAD (Coronary Artery Disease). CORUS CAD test has been clinically validated in two multicenter studies - COMPASS and PREDICT - in the US. The company also conducted DISCERN (diagnostic investigation of sudden cardiac event risk) multi-center clinical study along with its leading cardiologists in the area of cardiac arrhythmias. CardioDx is headquartered in Palo Alto, California, the US.

CardioDx Inc Key Recent Developments

Dec 19,2018: CardioDx Presents Comparative Effectiveness Claims Analysis Highlighting the Clinical Value of the Corus® CAD Precision Medicine Blood Test in Elderly Patients at the Gerontological Society of America 2018 Annual Meeting

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.